new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Rana Therapeutics Inc patents

Recent patent applications related to Rana Therapeutics Inc. Rana Therapeutics Inc is listed as an Agent/Assignee. Note: Rana Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Rana Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "R" | Rana Therapeutics Inc-related inventors




Date Rana Therapeutics Inc patents (updated weekly) - BOOKMARK this page
08/04/16Compositions and methods for treating amyotrophic lateral sclerosis
07/14/16Epigenetic regulators of frataxin
07/14/16Compositions and methods for modulating expression of frataxin
05/05/16Compositions and methods for modulating foxp3 expression
11/05/15Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers
11/05/15Methods of delivering multiple targeting oligonucleotides to a cell using non-nucleotide based cleavable linkers
11/05/15Multimeric oligonucleotides compounds having cleavable linkers
11/05/15Methods of delivering multiple targeting oligonucleotides to a cell using cleavable linkers
10/22/15Multimeric oligonucleotides compounds
09/10/15Compositions and methods for modulating smn gene family expression
09/03/15Multimeric oligonucleotide compounds
09/03/15Methods for modulating rna using pseudocircularization oligonucleotides
09/03/15Methods for modulating rna using 3' targeting oligonucleotides
08/20/15Compositions and methods for modulating gene expression
08/20/15Methods for modulating rna using 5' targeting oligonucleotides
08/20/155' targeting oligonucleotides for modulating rna
08/20/15Pseudocircularization oligonucleotides for modulating rna
08/20/15Targeting oligonucleotides and related methods for modulating fxn rna
08/20/15Euchromatic region targeting methods for modulating gene expression
08/13/153' targeting oligonucleotides for modulating rna
08/13/15Methods for selective targeting of heterochromatin forming non-coding rna
08/06/15Compositions for modulating gene expression
07/09/15Compositions and methods for modulating apoa1 and abca1 expression
06/11/15Compositions and methods for modulating atp2a2 expression
06/11/15Compositions and methods for modulating pten expression
06/04/15Compositions and methods for modulating mecp2 expression
05/21/15Compositions and methods for modulating gene expression
05/14/15Compositions and methods for modulating gene expression
05/14/15Compositions and methods for modulating hemoglobin gene family expression
05/14/15Compositions and methods for modulating bdnf expression
04/09/15Compositions and methods for modulating utrn expression
02/19/15Compositions and methods for modulating rna







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Rana Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Rana Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';